New location, new journey | XinBio shanghai operation center move to a new location
Date：2023-03-21 Views：
On March 17th, Suzhou XinBio Co., Ltd. held a housewarming ceremony at its Shanghai Operation Center, announcing its official settlement in Yunfei Building, No. 257 Xiangke Road, Pudong New Area, Shanghai. Meng Ruifeng, co-founder and CEO of XinBio, Dr. Chi Shen, co-founder and CTO, Zhao Guochuang, co-founder and CSO, and other management, upstream and downstream partners, as well as all employees of the company participated in the ceremony, witnessing important moments in XinBio's development process together.
Taking the relocation as an opportunity, the three co founders of XinBio, Meng Ruifeng, Dr. Chi Shen, and Mr. Zhao Guochuang, delivered speeches expressing their confidence in the future of the Shanghai Operation Center. They encouraged everyone to maintain determination, set goals, and make every effort to fully leverage the company's integrated advantages of self research and agency, and to develop rapidly in the CGT field from a new starting point. In addition, more than ten biopharmaceutical units, including Suzhou Mona Biotechnology Co., Ltd., JinXimeng Instrument Co., Ltd., Heyuan Liji Biotechnology Co., Ltd., Qingdao Xingsai Biotechnology Co., Ltd., and Shanghai Manbo Biopharmaceutical Technology Co., Ltd., congratulated on the smooth relocation and gave recognition and cooperation invitations to XinBio's scientific research achievements in the past few years.
In the afternoon, XinBio had an industry salon exchange with companies such as Mona Biotechnology, Jinximeng, Heyuan Liji, and Xingsai Biotechnology. Through reviewing their development history and introducing their product lines, they all expressed that the CGT field has entered the golden track. However, the overall improvement of the industry does not mean that it is easier to make money. Technical barriers, business breadth, and production capacity are still the core competitiveness of enterprises, and win-win cooperation is also the key to a better future.
Since its establishment, XinBio has adhered to its original intention and positioned itself as a "CGT fully automated integrated solution provider", constantly breaking through innovation. It has now extended its business to the three major fields of equipment, consumables, and reagents, and its market will gradually expand from East China to regions such as South China and North China. This relocation not only helps to expand the coverage of the East China market, but also accelerates communication and cooperation with top domestic biotech companies such as Zhangjiang Pharmaceutical Valley, empowering the upgrading of industry product quality and supporting the high-quality development of China's CGT field.
Recommended news
400-863-1188
Add:1st and 3rd floors of Qinghe Maker, No. 1368 Longqiao Road, Wujiang District, Suzhou City
E-mainl:info@szxxbio.com
Copyright © 2024 Suzhou XinBio Co., Ltd.
and/or its affiliates. All rights reserved.
